dipyridamole has been researched along with thromboxane b2 in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (84.38) | 18.7374 |
| 1990's | 4 (12.50) | 18.2507 |
| 2000's | 1 (3.13) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Best, LC; Martin, TJ; McGuire, MB; Preston, FE; Russell, RG; Segal, DS | 1 |
| Best, LC; Holland, TK; Jones, PB; Martin, TJ; McGuire, MB; Preston, FE; Russell, RG; Segal, DS | 1 |
| Furuta, K; Hattori, T; Ito, M; Nagamatsu, T; Nagao, T; Suzuki, Y | 1 |
| Kutti, J; Safai-Kutti, S; Vedin, A; Wilhelmsson, C | 1 |
| Fabris, F; Girolami, A; Luzzatto, G; Mazzucato, M | 1 |
| Heng, MC; Heng, MK; Song, MK | 1 |
| Fabris, F; Gerunda, GE; Girolami, A; Luzzatto, G; Zangrandi, F | 1 |
| Cronenwett, JL; Huntsman, WT; McDaniel, MD; Miett, TO | 1 |
| Boddi, M; Castellani, S; Fanara, F; Gensini, GF; Neri Serneri, GG; Pezza, A; Prisco, D; Rogasi, PG; Rostagno, C | 1 |
| Benak, A; Christakis, GT; Ivanov, J; Levitt, D; Madonik, MM; Mee, AV; Reilly, P; Teoh, KH; Weisel, RD; Wong, PY | 1 |
| Donadio, JV; Holley, KE; Ilstrup, DM; Romero, JC | 1 |
| Fujitani, RM; Marcus, CS; Nordestgaard, AG; Wilson, SE | 1 |
| Christakis, GT; Ivanov, J; Levitt, DS; Madonik, MM; Mee, AV; Reilly, PA; Rosenfeld, JM; Teoh, KH; Weisel, RD; Wong, PY | 1 |
| Aiken, JW; Humphrey, WR; Weselcouch, EO | 1 |
| Gay, WA; Karwande, SV; Subramanian, VA; Weksler, BB | 1 |
| Buckels, JA; Nordestgaard, AG; Wilson, SE | 1 |
| Blasevich, M; Borghi, A; Galli, C; Petroni, A; Socini, A | 1 |
| Geling, NG; Giessler, C; Mentz, P; Orlowa, ZR; Pawelski, KE; Taube, C | 1 |
| Dahl, ML; Matintalo, M; Puustinen, T; Uotila, P | 1 |
| Lewis, GP; Smith, JR | 1 |
| Cremer, KF; Joyal, M; Mehta, J; Pieper, JA | 1 |
| Bakhle, YS; Patel, K | 1 |
| Salokannel, J; Viinikka, L; Ylikorkala, O | 1 |
| de Gaetano, G; Dejana, E; Villa, S | 1 |
| Mehta, J; Mehta, P | 1 |
| Lorenz, R; Siess, W; Weber, PC | 1 |
| Chong, BH; Grace, CS; Rozenberg, MC | 1 |
| Castrucci, G; Ciabattoni, G; De Salvo, A; Parachini, M; Patrono, C; Pinca, E; Pugliese, F; Satta, MA | 1 |
| Cheng, JB; Cohan, VL; Eskra, JD; Griffiths, RJ; Pazoles, CJ; Pettipher, ER; Showell, HJ; Turner, CR; Watson, JW | 1 |
| Hoffmann, MW; Rauhöft, C; Terres, W | 1 |
| Filinger, EJ; Peredo, HA | 1 |
| Byrne, MF; Conroy, R; Cox, D; Dooley, M; Fitzgerald, DJ; Maree, AO | 1 |
5 trial(s) available for dipyridamole and thromboxane b2
| Article | Year |
|---|---|
Blood conservation with membrane oxygenators and dipyridamole.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Blood; Blood Platelets; Clinical Trials as Topic; Contraceptives, Oral, Combined; Coronary Artery Bypass; Dipyridamole; Hemoglobins; Hemorrhage; Humans; Leukocyte Count; Middle Aged; Oxygenators; Oxygenators, Membrane; Platelet Count; Platelet Factor 4; Postoperative Complications; Prospective Studies; Random Allocation; Thromboxane B2 | 1987 |
Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass.
Topics: Administration, Oral; Aspirin; Blood Platelets; Blood Transfusion; Cardiopulmonary Bypass; Dipyridamole; Erythrocyte Count; Female; Hemorrhage; Humans; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Platelet Count; Platelet Factor 4; Postoperative Complications; Prospective Studies; Random Allocation; Thromboxane B2 | 1988 |
Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis.
Topics: Aspirin; Blood Platelets; Blood Vessels; Coronary Disease; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Epoprostenol; Humans; Platelet Aggregation; Premedication; Thromboxane A2; Thromboxane B2 | 1987 |
[Long term effects of 50 mg acetylsalicylic acid alone and in combination with dipyridamole on platelet function after coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thromboxane B2; Time Factors | 1998 |
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
Topics: Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Body Weight; Cross-Over Studies; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Humans; Logistic Models; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Tablets, Enteric-Coated; Therapeutic Equivalency; Thromboxane B2; Treatment Outcome | 2006 |
27 other study(ies) available for dipyridamole and thromboxane b2
| Article | Year |
|---|---|
Dipyridamole and platelet function.
Topics: Anticoagulants; Cyclic AMP; Dipyridamole; Humans; In Vitro Techniques; Malondialdehyde; Platelet Aggregation; Thromboxane B2 | 1978 |
Mode of action of dipyridamole on human platelets.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine Diphosphate; Adenylyl Cyclases; Blood Platelets; Cell Membrane; Cyclic AMP; Cyclic GMP; Dipyridamole; Epinephrine; Epoprostenol; Humans; Malondialdehyde; Platelet Aggregation; Thromboxane B2; Time Factors | 1979 |
Studies on the antinephritic effect of plant components (4): Reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Berberine; Cholesterol; Creatinine; Dipyridamole; Drug Evaluation, Preclinical; In Vitro Techniques; Male; Nephritis; Plant Extracts; Platelet Aggregation; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Thromboxane B2 | 1992 |
Plasma concentrations of platelet-specific proteins and serum thromboxane B2 production in response to treatment with dipyridamole. A pilot study of 27 post-myocardial infarction patients.
Topics: Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Count; Platelet Factor 4; Thromboxane B2 | 1985 |
PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders.
Topics: Adult; Age Factors; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Dipyridamole; Female; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Count; Platelet Factor 4; Thromboxane B2 | 1985 |
Healing of necrobiotic ulcers with antiplatelet therapy. Correlation with plasma thromboxane levels.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Drug Therapy, Combination; Humans; Leg Ulcer; Male; Middle Aged; Necrobiosis Lipoidica; Radioimmunoassay; Thromboxane B2 | 1989 |
Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis.
Topics: Aged; beta-Thromboglobulin; Blood Platelets; Dipyridamole; Female; Humans; Isoindoles; Liver Cirrhosis; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation; Platelet Count; Platelet Factor 4; Thrombocytopenia; Thromboxane B2 | 1987 |
Effect of a selective thromboxane synthase inhibitor on arterial graft patency and platelet deposition in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Arteries; Aspirin; Benzofurans; Blood Platelets; Blood Vessel Prosthesis; Carotid Arteries; Dipyridamole; Dogs; Female; Indium; Polyethylene Terephthalates; Polytetrafluoroethylene; Radioisotopes; Random Allocation; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension.
Topics: beta-Thromboglobulin; Dipyridamole; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Thromboxanes | 1985 |
Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study.
Topics: Adult; Aspirin; Blood Platelets; Cell Survival; Creatinine; Diabetic Nephropathies; Dipyridamole; Drug Therapy, Combination; Female; Humans; Iothalamic Acid; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Proteinuria; Thromboxane B2 | 1988 |
Perioperative suppression of platelet adherence to small-diameter polytetrafluoroethylene (PTFE) grafts.
Topics: Animals; Aorta; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Combinations; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Polytetrafluoroethylene; Preoperative Care; Regional Blood Flow; Thromboxane B2; Vascular Patency | 1988 |
Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
Topics: Animals; Aspirin; Coronary Circulation; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Epoprostenol; Female; Indomethacin; Male; Platelet Aggregation; Thromboxane B2 | 1987 |
Platelet antagonists eliminate thromboembolic complications of small-diameter arterial prostheses.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Graft Occlusion, Vascular; Male; Platelet Aggregation; Polytetrafluoroethylene; Postoperative Complications; Rabbits; Thromboembolism; Thromboxane B2; Vascular Patency | 1987 |
Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Brain; Dipyridamole; Male; Microwaves; Nifedipine; Papaverine; Rats; Thromboxane B2; Thromboxanes; Vasomotor System | 1985 |
Significance of myocardial prostaglandin biosynthesis and the influence of mechanical loading, endogenous mediators and cardiovascular drugs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Dipyridamole; Epoprostenol; Heart; Heart Atria; Heart Ventricles; Myocardium; Propranolol; Prostaglandins; Prostaglandins E; Prostaglandins F; Rabbits; Thromboxane B2 | 1984 |
The effects of aspirin and dipyridamole on the metabolism of arachidonic acid in human platelets.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Humans; In Vitro Techniques; Leukotrienes; Male; Thromboxane B2 | 1983 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
Effects of diltiazem, dipyridamole, and their combination on hemostasis.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Adult; Benzazepines; Bleeding Time; Blood Pressure; Calcimycin; Diltiazem; Dipyridamole; Drug Therapy, Combination; Epinephrine; Heart Rate; Hemostasis; Humans; Male; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Thromboxane B2 | 1984 |
Thromboxane B2 (TxB2) metabolism in rat isolated lung and its inhibition by drugs.
Topics: Animals; Bromcresol Green; Dinoprostone; Dipyridamole; Furosemide; In Vitro Techniques; Lung; Male; Perfusion; Prostaglandins E; Rats; Rats, Inbred Strains; Thromboxane B2; Thromboxanes | 1983 |
Effect of prolonged treatment with acetylsalicylic acid and dipyridamole on platelet thromboxane A2 production in atherosclerotic subjects.
Topics: Aged; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Kinetics; Male; Thromboxane A2; Thromboxane B2; Thromboxanes | 1983 |
Bleeding time in rats: a comparison of different experimental conditions.
Topics: Anesthetics; Animals; Aspirin; Bleeding Time; Blood Coagulation; Blood Platelet Disorders; Dipyridamole; Disease Models, Animal; Epoprostenol; Heparin; Indomethacin; Rats; Tail; Thromboxane B2 | 1982 |
Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.
Topics: Arteriosclerosis; Aspirin; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Humans; Platelet Aggregation; Propranolol; Tachycardia; Thromboxane B2; Thromboxanes | 1981 |
Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1981 |
Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets.
Topics: Adenosine Diphosphate; Adult; Antibodies; Aspirin; Blood Platelets; Complement Fixation Tests; Dipyridamole; Female; Heparin; Humans; Indomethacin; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Platelet Factor 3; Thrombocytopenia; Thromboxane B2 | 1981 |
Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Cross Reactions; Diflunisal; Dipyridamole; Humans; Platelet Aggregation; Radioimmunoassay; Thromboxane B2; Thromboxanes | 1980 |
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenalectomy; Animals; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dipyridamole; Epinephrine; Humans; Kinetics; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Monocytes; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piroxicam; Propranolol; Purinones; Pyrimidinones; Thromboxane B2; Time Factors; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 1997 |
Effect of dipyridamole on prostanoid production in rat isolated atria.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Diabetes Mellitus, Experimental; Dinoprostone; Dipyridamole; Epoprostenol; Female; Heart Atria; In Vitro Techniques; Insulin; Prostaglandins; Rats; Rats, Wistar; Thromboxane A2; Thromboxane B2; Vasodilator Agents | 1999 |